Sign In
Buy TXMD
$1.97
-0.0700 (-3.43%)
At Close: Jun 03, 2026
TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021
06:50am, Monday, 26'th Jul 2021
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its second quarter 2021 financial results
TherapeuticsMD: The Long Road To Profitability
03:00pm, Thursday, 08'th Jul 2021
Although the market did not take favorably to recent Q1 numbers, there were some encouraging trends.
TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA
06:50am, Tuesday, 25'th May 2021
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD submits supplemental NDA to FDA for low-dose Bijuva
The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award
07:00am, Monday, 24'th May 2021
BOCA RATON, Fla.--(BUSINESS WIRE)--Sun Sentinel names TXMD as Top Workplace Winner
TherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q1 2021 Results - Earnings Call Transcript
01:45pm, Thursday, 06'th May 2021
TherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q1 2021 Results - Earnings Call Transcript
TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume
10:56am, Thursday, 06'th May 2021
TherapeuticsMD Inc (NASDAQ: TXMD) reported a Q1 EPS loss of $0.11 better than the analyst consensus estimate loss of $0.12, as well as an improvement from EPS loss of $0.21 a year ago. Sales of $1
TherapeuticsMD: Fighting To Regain Support Above $1.20
01:45pm, Wednesday, 21'st Apr 2021
Although sales grew by 30% in the fourth quarter, the market remains disinterested. ANNOVERA remains the key. Management are bullish on what is to come without restrictions in a post-covid world.
TherapeuticsMD: Great Product, But We Are Underwhelmed By Execution
09:37am, Wednesday, 21'st Apr 2021
TherapeuticsMD: Great Product, But We Are Underwhelmed By Execution
TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the Arm Friday
11:16am, Friday, 09'th Apr 2021
TherapeuticsMD (TXMD) stock is up on Friday after announcing approval for one of its hormone treatments in two parts of Europe. The post TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the
TherapeuticsMD Stock Price Increased Over 10% Pre-Market: Why It Happened
07:18am, Friday, 09'th Apr 2021
The stock price of TherapeuticsMD Inc (NASDAQ: TXMD) increased by over 10% pre-market. This is why it happened.
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, and Theramex, a dedicated women's health company, announced that BIJUVE® has
7 Reddit Penny Stocks Seeing the Most Chatter Today
12:40pm, Thursday, 18'th Mar 2021
Retail investors over on Reddit Penny Stocks are showing interest in quite a few interesting players today that investors will want to note. The post 7 Reddit Penny Stocks Seeing the Most Chatter Toda
EU & UK Conclude Decentralised Procedure Approval for Bijuva® (Estradiol & Progesterone) Capsules for Hormone Replacement Therapy
04:28am, Wednesday, 03'rd Mar 2021
LONDON--(BUSINESS WIRE)--Theramex, a global company specialised in women's health, announced today the Decentralised Procedure approval in several EU countries and the UK of BIJUVA® (1 mg estradiol /
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2020 Results - Earnings Call Transcript
01:13pm, Tuesday, 02'nd Mar 2021
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2020 Results - Earnings Call Transcript
TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates
09:05am, Tuesday, 02'nd Mar 2021
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -50.00% and 6.12%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
